Pharmanutra S.p.A. (BIT:PHN)

Market Cap	742.08M +52.4%
Revenue (ttm)	132.16M +13.8%
Net Income	20.00M +20.4%
EPS	2.09 +20.6%
Shares Out	9.58M
PE Ratio	37.15
Forward PE	30.50
Dividend	1.20 (1.55%)
Ex-Dividend Date	May 4, 2026

Volume	17,700
Average Volume	13,049
Open	77.20
Previous Close	77.20
Day's Range	76.80 - 78.30
52-Week Range	38.75 - 83.30
Beta	0.10
RSI	47.52
Earnings Date	May 14, 2026

About Pharmanutra

Pharmanutra S.p.A., a nutraceutical company, engages in the research and development and marketing of food supplements and medical devices in Europe, the Middle East, Far East, North America, South America, and internationally. The company produces and distributes raw materials and active ingredients for the food, pharmaceutical, and dietary supplement industries. It offers Sucrosomial, a delivery system that optimises nutrient transport and absorption for minimising gastrointestinal side effects; and Cetylated Fatty Acids, a formulation for mu...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2000
• Employees: 128
• Stock Exchange: Borsa Italiana
• Ticker Symbol: PHN

Financial Performance

In 2025, Pharmanutra's revenue was 132.16 million, an increase of 13.78% compared to the previous year's 116.15 million. Earnings were 20.00 million, an increase of 20.44%.